SARS-CoV-2 Variant Panel (4 x 0.5mL) -  Log in for Price

SARS-CoV-2 Variant Panel (4 x 0.5mL)

Catalog# NATSARS(COV2)-VP
Product Information:
    • Volume: 0.5mL
    • Units/Pack: 4
    • Storage Condition: 2-8°C
    • Hazardous Information: Non-Infectious
    • Matrix: Purified protein matrix treated with 0.09% sodium azide
    • Target: 50,000 copies/mL
    • Product Type: Panel
  • Classification/ Permits:
    RUO
    Learn More

    For Research Use Only. Not for use in Diagnostic Procedures.

    X

Veiw our complete list of Coronavirus products here

ZeptoMetrix external controls have demonstrated performance on a variety of molecular assays. The product has been tested with the Applied Biosystems QuantStudio or a real-time PCR thermal cycler and provides the expected results, however performance characteristics must be established by the end user.

Alpha (B.1.1.7) England/204820464/2020
Beta (B.1.351) South Africa/ KRISP-K005325/2020
Delta (B.1.617.2) USA/PHC658/2021;
Gamma (P.1) Japan/TY7-503/2021

  • Formulated with purified, intact organisms
  • Organisms are chemically modified to render them noninfectious
  • Refrigerator stable—store between 2 and 8°C
  • Purified protein matrix treated with 0.09% sodium azide
    4 x 0.5mL
  • Target concentration: 50,000 copies/mL

NATtrol SARS-COV-2 products are ready-to-use, inactivated full process controls designed to evaluate performance of molecular tests. They can be used for verification of assays, training of laboratory personnel and to monitor assay-kit lot performance. NATtrol products contain intact organisms and should be run in a manner similar to clinical specimens.

 

NATSARS(COV2)-VP is for research use only. Not for use in diagnostic procedures. Quality control materials should be used in accordance with local, state, federal, and accreditation requirements. This product is not intended to replace the manufacturer's controls provided with the assay. Propagation or commercialization are prohibited without prior written consent from Antylia Scientific.

When used as a control for nucleic acid tests, the same protocols as those used to amplify extracted clinical specimens should be employed.

The suitability and performance characteristics should be determined by your laboratory for each intended usage.

Welcome To